Repare Therapeutics Inc. (RPTX)

1.18

0.00 (0.00%)

At close: Mar 03, 2025, 3:59 PM

1.16

-1.69%

Pre-market: Mar 04, 2025, 07:57 AM EST

Repare Therapeutics Cash Flow Statement

Table Mode

Year	FY24	FY23	FY22	FY21	FY20	FY19	FY18	FY17
Net Income	-84.69M	-93.8M	-29.05M	-106.91M	-53.42M	-27.22M	-14.28M	-7.8M
Depreciation & Amortization	1.92M	1.95M	1.98M	1.47M	897K	605K	407K	102K
Stock-Based Compensation	23.17M	25.06M	19.69M	12.83M	2.54M	511K	306K	34K
Other Working Capital	n/a	-57.12M	10.9M	4.64M	42.4M	5.75M	-494K	-491K
Other Non-Cash Items	-16.85M	-5.19M	-3.94M	1.87M	890K	1.71M	1.13M	1.43M
Deferred Income Tax	n/a	n/a	3.62M	149K	588K	-629K	306K	-11K
Change in Working Capital	n/a	-55.18M	8.03M	4.79M	42.42M	6.59M	-484K	239K
Operating Cash Flow	-76.44M	-127.16M	322K	-85.8M	-6.08M	-18.43M	-12.62M	-6.01M
Capital Expenditures	n/a	-1.94M	-602K	-1.69M	-2.24M	-1.3M	-583K	-1.16M
Acquisitions	n/a	n/a	175.18M	40K	n/a	n/a	n/a	n/a
Purchase of Investments	-133.35M	-179.02M	-256.58M	-7.48M	-7.53M	n/a	n/a	n/a
Sales Maturities Of Investments	182.82M	259M	81.4M	7.45M	n/a	n/a	n/a	n/a
Other Investing Acitivies	n/a	n/a	-175.18M	14K	-7.53M	n/a	n/a	n/a
Investing Cash Flow	49.47M	78.04M	-175.78M	-1.68M	-9.76M	-1.3M	-583K	-1.16M
Debt Repayment	n/a	n/a	n/a	n/a	n/a	n/a	n/a	1.5M
Common Stock Repurchased	525K	689K	433K	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	542K	842K	880K	1.27M	15.8M	103.24M	n/a	28.96M
Financial Cash Flow	542K	842K	880K	95.56M	247.84M	103.24M	n/a	30.46M
Net Cash Flow	-26.55M	-48.25M	-174.91M	8.03M	231.39M	84.08M	-13.46M	23.3M
Free Cash Flow	-76.44M	-129.1M	-280K	-87.49M	-8.32M	-19.73M	-13.2M	-7.16M